AzTrials
AzTrials

BurnsNCT04372550

Effects of Early Exercise Rehabilitation in Severe Burns

A study testing Exercise in people with Burns, run by Universiteit Antwerpen at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

BACKGROUND: Postburn changes in glucose and protein metabolism are at their peak during the acute phase of severe burns. The resulting metabolic derangements lead to substantial muscle wasting, insulin resistance, which ultimately hampers full recovery and reintegration into society. Read more about this study

Who is it for?
Ages 18 to 64 years
Conditions the study is for
Burns
What is being tested?
Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteChina
Study dates
25 Nov 2019to Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 64 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • ≥40 - ≤70 %TBSA
  • Burn depth: 2nd deep / 3rd degree

Who cannot join

  • Electrical burn (except flash burns)
  • Associated injury: fracture lower limb
  • Diabetes Mellitus type 1
  • Central neurological/neuromuscular disorders (interfering with assessment/exercise)
  • Cognitive / psychological disorders (interfering with cooperation)
  • Cardiopulmonary disease (interfering with exercise safety)
  • Pregnancy
  • Palliative care

Trial locations and contacts

1 site in 1 country.

David R Schieffelers contact

+32465419848

david.schieffelers@uantwerp.be

China1 site, 1 recruiting
  • Institute of Burns, Wuhan Third Hospital & Tongren Hospital of Wuhan University

    Wuhan, Hubei, 430060

    Xie Weiguo, +8618071085225, wgxie@hotmail.com

    Recruiting

Other trials in China

About this study

Official title: Pathophysiological Mechanisms and Early Exercise Rehabilitation Counter Measures of Hypermetabolism and Muscle Wasting in Severe Burns.

BACKGROUND:

Postburn changes in glucose and protein metabolism are at their peak during the acute phase of severe burns. The resulting metabolic derangements lead to substantial muscle wasting, insulin resistance, which ultimately hampers full recovery and reintegration into society.

Read more

PURPOSE:

This randomized controlled trial was initiated to investigate the effects of exercise-based rehabilitation on muscle wasting, insulin resistance, and quality of life during the acute phase of severe adult burns.

METHODS:

Severly burned adults (40-80%TBSA) will be recruited from one of China's largest burn centres.

Subjects allocated to the intervention group will undergo a 6-12 week long exercise program in addition to standard care rehabilitation. As part of the exercise program, participants will carry out progressive resistance and aerobic training, initiated as soon as medical safety and patient cooperation allow. Exercise type and dosage will be chosen according to patient status in terms of grafts, mobility, and strength.

The control group will receive standard care rehabilitation only, including passive, assisted, active range of motion exercise, functional exercise, and scar treatment.

The results of this translational research will provide insight into the effects and mechanisms of exercise on both a fundamental and clinical spectrum.

Read the detailed description

The added exercise intervention is initiated in line with the following readiness criteria, which were checked prior to each training session:

Criteria:

  • Cardiorespiratory stability:
  • Mean arterial pressure (MAP) 60 - 110 mmHg
  • fraction of inspired oxygen (FiO2) <60%
  • partial pressure of oxygen / fraction of inspired oxygen (PaO2/FiO2) >200
  • Respiratory rate <40 bpm
  • Positive end expiratory pressure (PEEP) <10 cmH2O
  • no high inotropic doses (Dopamine >10 mcg/kg/min or Nor/adrenaline <0,1 mcg/kg/min)
  • Temp. 36 - 38,5°C
  • Richmond Agitation Sedation Scale (RASS) -2 - +2
  • Medical Doctor clearance
  • Medical research council (MRC) score lower limbs ≥3

Accordingly, the post burn starting time differs per enrolled subject.

Exercises are administered as in-bed exercises or out-of-bed exercises, depending on whether subjects are able and allowed to engage in out-of-bed mobility.

Exercise intensity for resistance training is set at 60% peak force based on a weekly peak force measurement by hand-held dynamometry, or on a 3 RM in case of out of bed exercises. Aerobic exercise intensity is set at 50-75% peak Watts determined by a weekly cycle ergometer or treadmill ramp protocol.

Conditions
Burns
Being tested
Exercise, Standard of Care
Keywords
Burns, Exercise rehabilitation, Exercise Therapy, Muscle wasting, Hypermetabolism, Insulin resistance
Medical subject headings
Burns, Muscular Atrophy, Insulin Resistance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseOther

    Resistance and aerobic exercise in addition to standard of care rehabilitation

  • Standard of CareOther

    Standard of care rehabilitation

Study groups in NCT04372550
Study groupRoleWhat they receive
Standard of CareActive comparatorStandard of care treatment: - including passive / assisted / active movements, stretching, functional exercise, scar treatment Duration: 6-12 weeks
Receives: Other: Standard of Care
ExerciseExperimentalStandard of care + added exercises Exercise type: resistance and aerobic exercise Resistance Exercise: 3x / week (manual resistance, free weights, machines) Aerobic exercise: 2x / week (cycle ergometer, treadmill) Duration: 6-12 weeks
Receives: Other: Exercise; Other: Standard of Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in quadriceps muscle layer thickness (QMLT)

    Method: B-mode ultrasound on the anterior aspect of the thigh. Technique: maximal and minimal pressure Location: measured at 1/2 and 2/3 of the distance between anterior superior iliac spine and the superior pole of the patella.

    Analysis: An average of 3 trials will be recorded and analyzed using dedicated software

    Measured: Baseline - 12 weeks

  2. Change in rectus femoris cross sectional area (RF-CSA)

    Method: B-mode ultrasound on the anterior aspect of the thigh. Technique: minimal pressure. Location: measured at the most proximal distance where the entire muscle belly is still visible on the ultrasound image.

    Analysis: An average of 3 trials will be recorded and analyzed using dedicated software.

    Measured: Baseline - 12 weeks

Secondary outcomes (1)
  1. Change in insulin resistance

    Method: HOMA-2 calculated by fasting plasma glucose and insulin, analysed by Western Blot Chemiluminescence

    Measured: Baseline and 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 May 2020
  2. Study start25 Nov 2019
  3. Primary completionOct 2021 (estimated)
  4. Study completionOct 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized Controlled Trial
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04372550
Sponsor's protocol ID
11B8619N
Status last verified
Aug 2020
First submitted
30 Apr 2020
Last updated
12 Aug 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Datasets will be made available upon request.

Questions about this trial

What is this clinical trial studying?

A study testing Exercise in people with Burns, run by Universiteit Antwerpen at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact David R Schieffelers (+32465419848, david.schieffelers@uantwerp.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in quadriceps muscle layer thickness (QMLT) (time frame: Baseline - 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in